World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 81 16536 15554 8307 7686 407 26805

David M. Jablons publications per year

The chart shows the history of publications by David M. Jablons between 1988 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David M. Jablons published across 38 years, from 1988 to 2025, averaging 12 papers a year. Output peaked at 44 publications in 2023. 12 of the 455 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1988 to 2025. Vertical axis: number of publications, 0 to 44. Peak 44 publications in 2023. 1988: 1 publication 1989: 4 publications 1990: 3 publications 1991: 0 publications 1992: 1 publication 1993: 1 publication 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 2 publications 1998: 4 publications 1999: 1 publication 2000: 9 publications 2001: 8 publications 2002: 6 publications 2003: 18 publications 2004: 22 publications 2005: 26 publications 2006: 20 publications 2007: 29 publications 2008: 17 publications 2009: 13 publications 2010: 22 publications 2011: 20 publications 2012: 17 publications 2013: 23 publications 2014: 15 publications 2015: 17 publications 2016: 15 publications 2017: 21 publications 2018: 16 publications 2019: 19 publications 2020: 9 publications 2021: 17 publications 2022: 3 publications 2023: 44 publications 2024: 5 publications 2025: 7 publications
1988 2025

455 publications in total across all disciplines

View publications per year as a table
David M. Jablons: publications per year, 1988 to 2025
Year Publications
1988 1
1989 4
1990 3
1991 0
1992 1
1993 1
1994 0
1995 0
1996 0
1997 2
1998 4
1999 1
2000 9
2001 8
2002 6
2003 18
2004 22
2005 26
2006 20
2007 29
2008 17
2009 13
2010 22
2011 20
2012 17
2013 23
2014 15
2015 17
2016 15
2017 21
2018 16
2019 19
2020 9
2021 17
2022 3
2023 44
2024 5
2025 7
Total 455
Download as CSV

David M. Jablons publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David M. Jablons sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 401–420 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 407 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918 407
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

David M. Jablons D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Jablons sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972 81
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

David M. Jablons is affiliated with the University of California, San Francisco in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with notable focus on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research, and Cell Biology.

The scientist's work covers a range of topics related to lung cancer and respiratory health, including:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Single-cell and Spatial Transcriptomics
  • Cancer Immunotherapy and Biomarkers
  • Neonatal Respiratory Health Research

David M. Jablons has contributed to multiple research papers published in well-known scientific journals. Recent publications include:

  • Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing, 2020, Cell
  • Discovering dominant tumor immune archetypes in a pan-cancer census, 2021, Cell
  • Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer, 2023, Journal of Clinical Oncology
  • The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC), 2020, Cancers
  • A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis, 2024, Journal of Clinical Investigation

The primary venues for their published work include:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell
  • Cancers

Frequent collaborators in their research are:

  • Johannes R. Kratz
  • Gavitt A. Woodard
  • Kirk D. Jones
  • Vivianne W. Ding
  • Matthew A. Gubens

The scope and concentration of David M. Jablons's research indicate a consistent focus on lung cancer biology, treatment strategies, and associated molecular mechanisms, integrating advanced methodologies such as single-cell RNA sequencing and exploring tumor immune environments across cancer types.

Best Publications

  • Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    David H. Johnson;Louis Fehrenbacher;William F. Novotny;Roy S. Herbst

  • Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

    Carolyn M Dresler;Jemi Olak;James E Herndon;William G Richards

  • SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

    Biao He;Liang You;Kazutsugu Uematsu;Keling Zang

  • Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.

    Ashley Maynard;Caroline E. McCoach;Julia K. Rotow;Lincoln Harris

  • Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

    Bin Bing S Zhou;Michael Peyton;Biao He;Changnian Liu

  • Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas

    Miguel Taron;Yukito Ichinose;Rafael Rosell;Tony Mok

  • Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression

    Kazutsugu Uematsu;Biao He;Liang You;Zhidong Xu

  • Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes : a possible role for interleukin 6 in cancer cachexia

    Andrew S. Greenberg;Richard P. Nordan;Joseph McIntosh;Juan Carlos Calvo

  • Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

    Josephine Chou;Yu-Ching Lin;Yu-Ching Lin;Yu-Ching Lin;Jae Kim;Liang You

  • Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

    Michele Carbone;Prasad S. Adusumilli;H. Richard Alexander;Paul Baas

  • A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells

    Biao He;Liang You;Kazutsugu Uematsu;Zhidong Xu

  • Antitumor activity of recombinant interleukin 6 in mice.

    J J Mulé;J K McIntosh;D M Jablons;S A Rosenberg

  • A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

    Johannes R Kratz;Jianxing He;Stephen K Van Den Eeden;Zhi-Hua Zhu

  • Natural History of Stage I Non-Small Cell Lung Cancer: Implications for Early Detection

    Dan J. Raz;Jason A. Zell;S-H. Ignatius Ou;David R. Gandara

  • Wnt signaling in lung cancer.

    Julien Mazieres;Biao He;Liang You;Zhidong Xu

  • Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer

    Julien Mazieres;Biao He;Liang You;Zhidong Xu

  • Granulocyte–Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non–Small-Cell Lung Cancer

    John Nemunaitis;Daniel Sterman;David Jablons;John W. Smith

  • Lung Cancer Staging and Prognosis

    Gavitt A. Woodard;Kirk D. Jones;David M. Jablons

  • Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.

    Liang You;Biao He;Zhidong Xu;Kazutsugu Uematsu

  • A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression

    Nobuhiro Okada;Chao Po Lin;Marcelo C. Ribeiro;Anne Biton

Frequent Co-Authors

Julien Mazieres
Julien Mazieres Paul Sabatier University
Frank McCormick
Frank McCormick University of California, San Francisco
Jian-Hua Mao
Jian-Hua Mao Lawrence Berkeley National Laboratory
Yucheng Wang
Yucheng Wang Huazhong Agricultural University
Rafael Rosell
Rafael Rosell Autonomous University of Barcelona
Lisa M. Coussens
Lisa M. Coussens Oregon Health & Science University
Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine
John Nemunaitis
John Nemunaitis Gradalis (United States)
Paul J. Wolters
Paul J. Wolters University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA opens up diverse career routes beyond the traditional M.D. path. For many students seeking flexibility or alternatives, fully online healthcare degrees provide an accessible option to boost their qualifications and advance their careers.

For aspiring nurse leaders, consider accredited programs like the best online dnp programs, which prepare nurses for top-tier clinical and executive roles. If your interests lie in pharmaceuticals, online pharmacy school programs offer a flexible, remote pathway into the pharmacy profession, making it easier to balance studies with life commitments.

The growth of digital health records has driven demand for experts in informatics. If technology and data management appeal to you, healthcare informatics degree programs can prepare you for vital roles managing patient information and supporting clinical decisions.

Alternatively, if you’re looking for a quicker route into healthcare, medical coding offers stable job prospects with fewer prerequisites. You can learn more about program options and pricing by researching medical billing and coding cost.

Best Scientists Citing David M. Jablons

Trending Scientists

Recently Published Articles